Longboard Pharmaceuticals (LBPH) News Today → This unknown company solves the biggest issue with AI (From Manward Press) (Ad) Free LBPH Stock Alerts $21.14 +0.79 (+3.88%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 11:00 PM | morningstar.comLongboard Pharmaceuticals Inc LBPHMay 11, 2024 | americanbankingnews.comHC Wainwright Analysts Lower Earnings Estimates for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)May 10, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 7.3%Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Down 7.3%May 10, 2024 | marketbeat.comQ2 2024 EPS Estimates for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Cut by HC WainwrightLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) - Equities research analysts at HC Wainwright lowered their Q2 2024 earnings per share estimates for Longboard Pharmaceuticals in a research note issued to investors on Tuesday, May 7th. HC Wainwright analyst P. Trucchio now forecasts thMay 8, 2024 | americanbankingnews.comLongboard Pharmaceuticals (NASDAQ:LBPH) Given "Buy" Rating at HC WainwrightMay 7, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Trading 6.1% Higher Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Up 6.1%May 7, 2024 | marketbeat.comLongboard Pharmaceuticals' (LBPH) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and set a $60.00 price objective on shares of Longboard Pharmaceuticals in a research note on Tuesday.May 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for Longboard Pharmaceuticals Amidst Positive Clinical Progress and Market Potential for BexicaserinMay 7, 2024 | americanbankingnews.comLongboard Pharmaceuticals' (LBPH) Overweight Rating Reaffirmed at Cantor FitzgeraldMay 6, 2024 | businesswire.comLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)May 6, 2024 | americanbankingnews.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Average Recommendation of "Buy" by AnalystsMay 4, 2024 | finance.yahoo.comLongboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic DevelopmentsMay 3, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Shares Down 5.7% Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 5.7%May 3, 2024 | msn.comLongboard Pharmaceuticals EPS of -$0.42 beats by $0.07May 3, 2024 | marketbeat.comCantor Fitzgerald Reiterates "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)Cantor Fitzgerald reissued an "overweight" rating and set a $60.00 price objective on shares of Longboard Pharmaceuticals in a report on Friday.May 3, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Price Target Increased to $34.00 by Analysts at WedbushWedbush boosted their price objective on Longboard Pharmaceuticals from $32.00 to $34.00 and gave the company an "outperform" rating in a report on Friday.May 2, 2024 | markets.businessinsider.comBuy Rating Affirmed on Longboard Pharmaceuticals with Promising Bexicaserin Developments and Regulatory Milestones AheadMay 2, 2024 | investorplace.comLBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024May 2, 2024 | businesswire.comLongboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 2, 2024 | msn.comBaird Initiates Coverage of Longboard Pharmaceuticals (LBPH) with Outperform RecommendationMay 1, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Coverage Initiated by Analysts at Robert W. BairdRobert W. Baird assumed coverage on shares of Longboard Pharmaceuticals in a research note on Wednesday. They set an "outperform" rating and a $36.00 target price for the company.April 29, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Trading 6.2% Higher Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Up 6.2%April 27, 2024 | marketbeat.com480,828 Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Purchased by Jennison Associates LLCJennison Associates LLC acquired a new stake in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 480,828 shares of the company's stock,April 18, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Trading Up 5.1%Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 5.1%April 17, 2024 | markets.businessinsider.comBexicaserin’s Promising Future: Buy Rating Justified by Strong Clinical Data and Potential Blockbuster StatusApril 13, 2024 | marketbeat.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Sees Large Increase in Short InterestLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 4,950,000 shares, an increase of 32.4% from the March 15th total of 3,740,000 shares. Currently, 14.9% of the company's shares are sold short. Based on an average trading volume of 644,800 shares, the days-to-cover ratio is presently 7.7 days.April 11, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Trading Up 8%Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 8%April 11, 2024 | marketbeat.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Average Rating of "Buy" from BrokeragesShares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Get Free Report) have been assigned a consensus rating of "Buy" from the six analysts that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year priceApril 4, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Up 6.2%Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Up 6.2%April 3, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 5.1%Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 5.1%April 3, 2024 | businesswire.comLongboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15April 2, 2024 | businesswire.comLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)March 27, 2024 | finance.yahoo.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50%March 27, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $20.11Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $20.11March 18, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)HC Wainwright reiterated a "buy" rating and issued a $60.00 price target on shares of Longboard Pharmaceuticals in a research note on Friday.March 18, 2024 | marketbeat.comLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH) to Post FY2024 Earnings of ($2.04) Per Share, Cantor Fitzgerald ForecastsLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for shares of Longboard Pharmaceuticals in a research note issued to investors on Wednesday, March 13th. Cantor Fitzgerald analyst J. SMarch 16, 2024 | finance.yahoo.comLBPH Apr 2024 17.500 putMarch 15, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Issued By B. RileyLongboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) - Equities researchers at B. Riley issued their Q2 2024 earnings per share estimates for shares of Longboard Pharmaceuticals in a research note issued on Wednesday, March 13th. B. Riley analyst K. Patel forecasts that the company will poMarch 14, 2024 | finance.yahoo.comLongboard Pharmaceuticals Inc Reports Full Year 2023 Financial ResultsMarch 13, 2024 | markets.businessinsider.comBuy Rating Affirmed: Longboard Pharmaceuticals’ Bexicaserin Shows Promising Efficacy and Strategic MilestonesMarch 13, 2024 | marketbeat.comPolar Capital Holdings Plc Takes $5.56 Million Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Polar Capital Holdings Plc bought a new stake in shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,000,000 shares of the company's stock, valued at approxMarch 12, 2024 | benzinga.comRecap: Longboard Pharmaceuticals Q4 EarningsMarch 12, 2024 | businesswire.comLongboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate UpdatesMarch 7, 2024 | marketbeat.comFmr LLC Sells 456,084 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)Fmr LLC reduced its stake in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH - Free Report) by 17.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,113,073 shares of the company'sMarch 3, 2024 | finance.yahoo.comLBPH May 2024 30.000 callMarch 1, 2024 | businesswire.comLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)February 24, 2024 | finance.yahoo.comLBPH Mar 2024 22.500 callFebruary 24, 2024 | finance.yahoo.comLBPH Aug 2024 15.000 putFebruary 23, 2024 | marketbeat.comLongboard Pharmaceuticals (NASDAQ:LBPH) Stock Price Up 5.6%Longboard Pharmaceuticals (NASDAQ:LBPH) Trading 5.6% HigherFebruary 22, 2024 | benzinga.comLongboard Pharmaceuticals Stock (NASDAQ:LBPH), Short Interest Report Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Drop BOMBSHELL June 13th? (Ad)Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence. LBPH Media Mentions By Week LBPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LBPH News Sentiment▼0.010.55▲Average Medical News Sentiment LBPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LBPH Articles This Week▼92▲LBPH Articles Average Week Get Longboard Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SAGE News Today PLRX News Today YMAB News Today TNGX News Today EOLS News Today SIGA News Today ARCT News Today COGT News Today PRTC News Today AUPH News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LBPH) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportPharma Giant Makes Deal with a "Drug Smuggler"Behind the MarketsTop 5 Tech Stocks to Buy for 2024Daily Market Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longboard Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
